NGENLA READY-TO-USE PEN CONTAINING SOLUTION FOR INJECTION 24 mg/1.2 mL

Somatrogon vs. Somatropin

Growth hormone deficiency (GHD) is a medical condition caused by insufficient production of growth hormone (GH), leading to various developmental and metabolic complications in both children and adults. Recombinant human growth hormone (rhGH) therapies have been developed to treat this condition effectively. Among the treatments available, somatrogon and somatropin are two prominent options that have distinct characteristics. This article […]

Somatrogon vs. Somatropin Read More »